Clinical trial
Mantle Irradiation for Hodgkin's Disease
NCT00165269 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00165269 |
|---|---|
| Title | Mantle Irradiation for Hodgkin's Disease |
| Official title | Mantle Irradiation for Selected Hodgkin's Disease Patients With Stage IA-IIA Disease |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Massachusetts General Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hodgkin's Disease |
| Intervention type | Procedure |
| Interventions | Mantle irradiation |
| Enrollment | 100 |
| Start date | May 1, 1992 |
| Primary completion | Jun 1, 2000 |
| Completion | Feb 1, 2008 |
| First posted | Sep 14, 2005 |
| Last update posted | Nov 2, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: